Article
Glutamine depletion by crisantaspase hinders the growth of human hepatocellular carcinoma xenografts.
British journal of cancer - 9 Sept 2014
Chiu M, Tardito S, Pillozzi S, Arcangeli A, Armento A, Uggeri J, Missale G, Bianchi M G, Barilli A, Dall'Asta V, Campanini N, Silini E M, Fuchs J, Armeanu-Ebinger S, Bussolati O
Abstract excerpt
BACKGROUND: A subset of human hepatocellular carcinomas (HCC) exhibit mutations of β-catenin gene CTNNB1 and overexpress Glutamine synthetase (GS). The CTNNB1-mutated HCC cell line HepG2 is sensitive to glutamine starvation induced in vitro with the antileukemic drug Crisantaspase and the GS inhibitor methionine-L-sulfoximine (MSO). METHODS: Immunodeficient mice with subcutaneous xenografts of the CTNNB1-mutated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
